Report

Culture Reimagined: How Pharmaceutical Firms Can Use Data and AI with Confidence

Pharma and biotech companies face a pivotal next step in addressing the increased complexity of production while balancing mounting cost pressures with the need to ensure product quality, security of supply and regulatory compliance. Findings from AspenTech® and Longitude’s recent market survey revealed that digital culture and technology adoption provide a competitive edge – but adoption is slow.

On Demand Webinar

How are Pharmaceutical and Biotech Companies Using Data and AI with Confidence?

Pharma and biotech companies face a pivotal next step in addressing the increased complexity of production while balancing mounting cost pressures with the need to ensure product quality, security of supply and regulatory compliance.

Case Study

GlaxoSmithKline Speeds up Batch Release Time: A Study in Digital Transformation

GlaxoSmithKline (GSK) wanted to review the structure of its batch production record and associated workflows as part of a continuous improvement process. Reducing batch review time usually results in faster batch cycle time, meaning higher throughput at the production facility and faster cash-to-cash cycle time. AspenTech was selected for this process due to integration with other solutions, such as Aspen InfoPlus.21® and GSK’s existing plant automation software (DCS). The pilot project was a resounding success, reducing order preparation time by 95% and record review time by over 50%.

Camo Analytics

Camo Analyticsの買収について

Whats New

Delivering higher levels of profitability and sustainability with Industrial AI. We embed AI into our most widely adopted, industry-leading products and solutions, and empower data scientists to collaborate with domain experts to enrich models.

Page 1 of 1